List of insiders holdings for Taysha Gene Therapies Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Manning Paul B 10% Owner |
2024-07-01 08:00:07 | 1,333,333 23,517,778 |
24,851,111 | Form 4 |
| 2 | Session R.A. II 10% Owner |
2023-07-14 16:00:39 | 8,871,747 282,180 |
9,153,927 | Form 4 |
| 3 | Audentes Therapeutics Inc. Astellas Pharma Inc. 10% Owner |
2023-08-18 17:16:27 | 7,266,342 0 |
7,266,342 | Form 13D |
| 4 | Nolan Sean P. Chief Executive Officer |
2025-01-03 17:38:40 | 2,970,858 1,535,545 |
4,506,403 | Form 4 |
| 5 | Stalfort John A III Director |
2024-05-31 16:18:25 | 1,197,041 884,290 |
2,081,331 | Form 4 |
| 6 | Nagendran Sukumar President and Head of R&D |
2025-01-03 17:36:40 | 1,546,843 0 |
1,546,843 | Form 4 |
| 7 | PRASAD SUYASH CMO and Head of R&D |
2022-07-07 16:30:28 | 530,589 0 |
530,589 | Form 4 |
| 8 | Donenberg Phillip B. Director |
2024-05-31 16:18:21 | 261,771 0 |
261,771 | Form 4 |
| 9 | Sepp-Lorenzino Laura Director |
2024-05-31 16:15:09 | 147,660 0 |
147,660 | Form 4 |
| 10 | Long Alison S Director |
2024-05-31 16:18:23 | 147,660 0 |
147,660 | Form 4 |
| 11 | Reape Kathleen Director |
2023-06-26 16:50:09 | 36,200 0 |
36,200 | Form 4 |
| 12 | Alam Kamran CHIEF FINANCIAL OFFICER |
2025-04-10 16:15:13 | 12,462 0 |
12,462 | Form 4/A |